ID   FABI_BACCR              Reviewed;         256 AA.
AC   Q81GI3;
DT   03-MAY-2011, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   05-FEB-2025, entry version 132.
DE   RecName: Full=Enoyl-[acyl-carrier-protein] reductase [NADH] FabI;
DE            Short=ENR;
DE            EC=1.3.1.9;
DE   AltName: Full=NADH-dependent enoyl-ACP reductase;
GN   Name=fabI; OrderedLocusNames=BC_1216;
OS   Bacillus cereus (strain ATCC 14579 / DSM 31 / CCUG 7414 / JCM 2152 / NBRC
OS   15305 / NCIMB 9373 / NCTC 2599 / NRRL B-3711).
OC   Bacteria; Bacillati; Bacillota; Bacilli; Bacillales; Bacillaceae; Bacillus;
OC   Bacillus cereus group.
OX   NCBI_TaxID=226900;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 14579 / DSM 31 / CCUG 7414 / JCM 2152 / NBRC 15305 / NCIMB
RC   9373 / NCTC 2599 / NRRL B-3711;
RX   PubMed=12721630; DOI=10.1038/nature01582;
RA   Ivanova N., Sorokin A., Anderson I., Galleron N., Candelon B., Kapatral V.,
RA   Bhattacharyya A., Reznik G., Mikhailova N., Lapidus A., Chu L., Mazur M.,
RA   Goltsman E., Larsen N., D'Souza M., Walunas T., Grechkin Y., Pusch G.,
RA   Haselkorn R., Fonstein M., Ehrlich S.D., Overbeek R., Kyrpides N.C.;
RT   "Genome sequence of Bacillus cereus and comparative analysis with Bacillus
RT   anthracis.";
RL   Nature 423:87-91(2003).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) IN COMPLEX WITH NAD AND INHIBITOR,
RP   AND SUBUNIT.
RX   PubMed=20800575; DOI=10.1016/j.bbrc.2010.08.083;
RA   Kim S.J., Ha B.H., Kim K.H., Hong S.K., Shin K.J., Suh S.W., Kim E.E.;
RT   "Dimeric and tetrameric forms of enoyl-acyl carrier protein reductase from
RT   Bacillus cereus.";
RL   Biochem. Biophys. Res. Commun. 400:517-522(2010).
CC   -!- FUNCTION: Catalyzes the reduction of a carbon-carbon double bond in an
CC       enoyl moiety that is covalently linked to an acyl carrier protein
CC       (ACP). Involved in the elongation cycle of fatty acid which are used in
CC       the lipid metabolism (By similarity). {ECO:0000250}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 2,3-saturated acyl-[ACP] + NAD(+) = a (2E)-enoyl-[ACP] +
CC         NADH + H(+); Xref=Rhea:RHEA:10240, Rhea:RHEA-COMP:9925, Rhea:RHEA-
CC         COMP:9926, ChEBI:CHEBI:15378, ChEBI:CHEBI:57540, ChEBI:CHEBI:57945,
CC         ChEBI:CHEBI:78784, ChEBI:CHEBI:78785; EC=1.3.1.9;
CC   -!- PATHWAY: Lipid metabolism; fatty acid biosynthesis.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000269|PubMed:20800575}.
CC   -!- SIMILARITY: Belongs to the short-chain dehydrogenases/reductases (SDR)
CC       family. FabI subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE016877; AAP08201.1; -; Genomic_DNA.
DR   RefSeq; NP_831000.1; NC_004722.1.
DR   RefSeq; WP_000421886.1; NZ_CP034551.1.
DR   PDB; 3OJE; X-ray; 3.02 A; A=1-256.
DR   PDB; 3OJF; X-ray; 2.20 A; A/B/C/D=1-256.
DR   PDB; 5YCR; X-ray; 1.96 A; A/B/C/D=1-256.
DR   PDB; 5YCS; X-ray; 1.95 A; A/B/C/D=1-256.
DR   PDB; 5YCV; X-ray; 1.85 A; A/B/C/D=1-256.
DR   PDB; 5YCX; X-ray; 1.70 A; A=1-256.
DR   PDBsum; 3OJE; -.
DR   PDBsum; 3OJF; -.
DR   PDBsum; 5YCR; -.
DR   PDBsum; 5YCS; -.
DR   PDBsum; 5YCV; -.
DR   PDBsum; 5YCX; -.
DR   AlphaFoldDB; Q81GI3; -.
DR   SMR; Q81GI3; -.
DR   STRING; 226900.BC_1216; -.
DR   MetOSite; Q81GI3; -.
DR   GeneID; 75084525; -.
DR   KEGG; bce:BC1216; -.
DR   PATRIC; fig|226900.8.peg.1186; -.
DR   HOGENOM; CLU_010194_10_1_9; -.
DR   OrthoDB; 9803628at2; -.
DR   BRENDA; 1.3.1.10; 648.
DR   BRENDA; 1.3.1.9; 648.
DR   UniPathway; UPA00094; -.
DR   EvolutionaryTrace; Q81GI3; -.
DR   Proteomes; UP000001417; Chromosome.
DR   GO; GO:1902494; C:catalytic complex; IDA:UniProtKB.
DR   GO; GO:0004318; F:enoyl-[acyl-carrier-protein] reductase (NADH) activity; IDA:UniProtKB.
DR   GO; GO:0141148; F:enoyl-[acyl-carrier-protein] reductase (NADPH) activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:UniProtKB.
DR   GO; GO:0070401; F:NADP+ binding; IDA:UniProtKB.
DR   GO; GO:0036094; F:small molecule binding; EXP:DisProt.
DR   GO; GO:0030497; P:fatty acid elongation; ISS:UniProtKB.
DR   CDD; cd05372; ENR_SDR; 1.
DR   FunFam; 3.40.50.720:FF:000127; Enoyl-[acyl-carrier-protein] reductase [NADH]; 1.
DR   Gene3D; 3.40.50.720; NAD(P)-binding Rossmann-like Domain; 1.
DR   InterPro; IPR014358; Enoyl-ACP_Rdtase_NADH.
DR   InterPro; IPR036291; NAD(P)-bd_dom_sf.
DR   InterPro; IPR002347; SDR_fam.
DR   PANTHER; PTHR43159; ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE; 1.
DR   PANTHER; PTHR43159:SF2; ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH], CHLOROPLASTIC; 1.
DR   Pfam; PF13561; adh_short_C2; 1.
DR   PIRSF; PIRSF000094; Enoyl-ACP_rdct; 1.
DR   PRINTS; PR00081; GDHRDH.
DR   SUPFAM; SSF51735; NAD(P)-binding Rossmann-fold domains; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Fatty acid biosynthesis; Fatty acid metabolism;
KW   Lipid biosynthesis; Lipid metabolism; NAD; NADP; Nucleotide-binding;
KW   Oxidoreductase; Reference proteome.
FT   CHAIN           1..256
FT                   /note="Enoyl-[acyl-carrier-protein] reductase [NADH] FabI"
FT                   /id="PRO_0000407976"
FT   ACT_SITE        147
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        157
FT                   /note="Proton acceptor"
FT   BINDING         13
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:20800575"
FT   BINDING         19..20
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:20800575"
FT   BINDING         66..67
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:20800575"
FT   BINDING         94
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:20800575"
FT   BINDING         97
FT                   /ligand="substrate"
FT   BINDING         164
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:20800575"
FT   BINDING         193..197
FT                   /ligand="NAD(+)"
FT                   /ligand_id="ChEBI:CHEBI:57540"
FT                   /evidence="ECO:0000269|PubMed:20800575"
FT   SITE            205
FT                   /note="Involved in acyl-ACP binding"
FT                   /evidence="ECO:0000250"
FT   TURN            3..6
FT                   /evidence="ECO:0007829|PDB:5YCX"
FT   STRAND          8..12
FT                   /evidence="ECO:0007829|PDB:5YCX"
FT   HELIX           20..30
FT                   /evidence="ECO:0007829|PDB:5YCX"
FT   STRAND          34..41
FT                   /evidence="ECO:0007829|PDB:5YCX"
FT   HELIX           42..53
FT                   /evidence="ECO:0007829|PDB:5YCX"
FT   STRAND          55..58
FT                   /evidence="ECO:0007829|PDB:3OJF"
FT   STRAND          61..64
FT                   /evidence="ECO:0007829|PDB:5YCX"
FT   HELIX           70..83
FT                   /evidence="ECO:0007829|PDB:5YCX"
FT   STRAND          88..92
FT                   /evidence="ECO:0007829|PDB:5YCX"
FT   HELIX           99..101
FT                   /evidence="ECO:0007829|PDB:5YCV"
FT   STRAND          102..104
FT                   /evidence="ECO:0007829|PDB:3OJF"
FT   HELIX           106..108
FT                   /evidence="ECO:0007829|PDB:5YCV"
FT   HELIX           113..132
FT                   /evidence="ECO:0007829|PDB:5YCX"
FT   TURN            133..135
FT                   /evidence="ECO:0007829|PDB:5YCX"
FT   STRAND          140..147
FT                   /evidence="ECO:0007829|PDB:5YCX"
FT   HELIX           148..150
FT                   /evidence="ECO:0007829|PDB:5YCV"
FT   TURN            155..157
FT                   /evidence="ECO:0007829|PDB:5YCV"
FT   HELIX           162..178
FT                   /evidence="ECO:0007829|PDB:5YCX"
FT   HELIX           179..181
FT                   /evidence="ECO:0007829|PDB:5YCX"
FT   STRAND          183..190
FT                   /evidence="ECO:0007829|PDB:5YCX"
FT   HELIX           196..198
FT                   /evidence="ECO:0007829|PDB:3OJF"
FT   STRAND          200..202
FT                   /evidence="ECO:0007829|PDB:5YCV"
FT   HELIX           205..214
FT                   /evidence="ECO:0007829|PDB:5YCX"
FT   HELIX           223..234
FT                   /evidence="ECO:0007829|PDB:5YCX"
FT   HELIX           236..238
FT                   /evidence="ECO:0007829|PDB:5YCX"
FT   STRAND          245..249
FT                   /evidence="ECO:0007829|PDB:5YCX"
FT   HELIX           252..255
FT                   /evidence="ECO:0007829|PDB:5YCX"
SQ   SEQUENCE   256 AA;  27740 MW;  66780350F497CA31 CRC64;
     MELLQGKTFV VMGVANQRSI AWGIARSLHN AGAKLIFTYA GERLERNVRE LADTLEGQES
     LVLPCDVTND EELTACFETI KQEVGTIHGV AHCIAFANRD DLKGEFVDTS RDGFLLAQNI
     SAFSLTAVAR EAKKVMTEGG NILTLTYLGG ERVVKNYNVM GVAKASLEAS VKYLANDLGQ
     HGIRVNAISA GPIRTLSAKG VGDFNSILRE IEERAPLRRT TTQEEVGDTA VFLFSDLARG
     VTGENIHVDS GYHILG
//
